Literature DB >> 20878038

How to clinically assess and treat muscle overactivity in spastic paresis.

Alain P Yelnik1, Olivier Simon, Bernard Parratte, Jean Michel Gracies.   

Abstract

OBJECTIVE: This educational paper aims to describe, in adult patients, the different aspects of muscle overactivity after a central nervous system lesion, including spasticity, spastic dystonia and spastic co-contraction, the assessment of their symptoms and consequences, and therapeutic options. DISCUSSION AND
CONCLUSION: Clinical evaluation involves the assessment of passive range of motion, angle of catch or clonus, active range of motion, rapid alternating movements and functional consequences. A number of scales have been developed to assess patients with spastic paresis, involving both patient and caregivers. Not all persons with spasticity require treatment, which is considered only when muscle overactivity is disabling or problematic. A list of personal objectives may be proposed for each patient, which will drive assessment and treatment. Prior to treatment the patient must be informed of the intended benefits and possible adverse events. Clinical evaluation may be supported by the use of transient neuromuscular blocks and/or instrumental analysis. Physical therapies usually represent the mainstay of treatment. Self-rehabilitation with stretching and active exercises, intramuscular injections of botulinum toxin, alcohol or phenol injections, oral or intrathecal drugs, and surgery comprise the treatment options available to the clinician. Follow-up must be scheduled in order to assess the benefits of treatment and possible adverse events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878038     DOI: 10.2340/16501977-0613

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  15 in total

1.  Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.

Authors:  Andrea Santamato; Francesco Panza; Maurizio Ranieri; Vincenza Frisardi; Maria Francesca Micello; Serena Filoni; Francesca Fortunato; Domenico Intiso; Mario Basciani; Giancarlo Logroscino; Pietro Fiore
Journal:  J Neural Transm (Vienna)       Date:  2012-09-07       Impact factor: 3.575

2.  Cohort study of atypical pressure ulcers development.

Authors:  Efraim Jaul
Journal:  Int Wound J       Date:  2013-02-04       Impact factor: 3.315

3.  Effects of a dynamic progressive orthotic intervention for chronic hemiplegia: a case series.

Authors:  Barbara M Doucet; Joni A Mettler
Journal:  J Hand Ther       Date:  2012-11-11       Impact factor: 1.950

Review 4.  Botulinum Toxin Treatment in Multiple Sclerosis-a Review.

Authors:  Yasaman Safarpour; Tahereh Mousavi; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2017-08-17       Impact factor: 3.598

5.  The short-term effect of ultrasound and peripheral nerve stimulator-guided femoral nerve block with phenol on the outcomes of patients with traumatic spinal cord injury.

Authors:  Yasin Demir; Ayça Uran Şan; Serdar Kesikburun; Evren Yaşar; Bilge Yılmaz
Journal:  Spinal Cord       Date:  2018-05-22       Impact factor: 2.772

6.  Treatment of spasticity in spinal cord injury with botulinum toxin.

Authors:  Ramiro Palazón-García; Mónica Alcobendas-Maestro; Ana Esclarin-de Ruz; Ana María Benavente-Valdepeñas
Journal:  J Spinal Cord Med       Date:  2018-06-05       Impact factor: 1.985

7.  Monitoring Involuntary Muscle Activity in Acute Patients with Upper Motor Neuron Lesion by Wearable Sensors: A Feasibility Study.

Authors:  Andrea Merlo; Maria Giulia Montecchi; Francesco Lombardi; Xhejsi Vata; Aurora Musi; Mirco Lusuardi; Roberto Merletti; Isabella Campanini
Journal:  Sensors (Basel)       Date:  2021-04-30       Impact factor: 3.576

Review 8.  Botulinum Neurotoxin Type A in Neurology: Update.

Authors:  Marco Orsini; Marco Antonio Araujo Leite; Tae Mo Chung; Wladimir Bocca; Jano Alves de Souza; Olivia Gameiro de Souza; Rayele Priscila Moreira; Victor Hugo Bastos; Silmar Teixeira; Acary Bulle Oliveira; Bruno da Silva Moraes; André Palma Matta; Luis Jorge Jacinto
Journal:  Neurol Int       Date:  2015-09-24

Review 9.  OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review.

Authors:  Luba Nalysnyk; Spyridon Papapetropoulos; Philip Rotella; Jason C Simeone; Katharine E Alter; Alberto Esquenazi
Journal:  BMC Neurol       Date:  2013-09-08       Impact factor: 2.474

10.  Extracorporeal Shock Wave Stimulation as Alternative Treatment Modality for Wrist and Fingers Spasticity in Poststroke Patients: A Prospective, Open-Label, Preliminary Clinical Trial.

Authors:  Robert Dymarek; Jakub Taradaj; Joanna Rosińczuk
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.